

著者 | 題名 | 論文 | |
1 | Endo H, Niizuma K, Fujimura M, Sato K, Inoue T, Osawa SI, Tominaga T | Ruptured cerebral microaneurysm diagnosed by 3D fast spin-echo T1 imaging with variable flip angles | J Stroke Cerebrovasc Dis, in press |
2 | Kochi R, Endo H, Niizuma K, Fujimura M, Sato K, Inoue T, Osawa SI, Tominaga T | Outflow occlusion with occipital artery-posterior inferior cerebellar artery bypass for growing vertebral artery fusiform aneurysm with ischemic onset: A case report | J Stroke Cerebrovasc Dis, in press |
3 | Rashad S, Endo H, Sultan AE Shimizu H, Fujimura M, Sato K, Matsumoto Y, Tominaga T | Therapeutic clip occlusion of the anterior choroidal artery involved with partially thrombosed fusiform aneurysm: A case report | J Stroke Cerebrovasc Dis, in press |
4 | Omodaka S Endo H, Fujimura M, Niizuma K, Sato K, Matsumoto Y, Tominaga T | High-grade Cerebral Arteriovenous Malformation Treated with Targeted Embolization of a Ruptured Site: Wall Enhancement of an Intranidal Aneurysm as a Sign of Ruptured Site (NMC) | Neurol Med Chir (Tokyo), in press |
5 | Ogawa Y, Kawaguchi T, Tominaga T | Outcome and mid-term prognosis after maximum and radical removal of craniopharyngiomas with the priority to the extended trassphenoidal approach -A single center experience | Clinical Neurology and Neurosurgery 125, 41-46, 2014 |
6 | Ogawa Y, Watanabe M, Tominaga T | Spontaneous Alteration from Rathke’s Cleft Cyst to Craniopharyngioma -Possible Involvement of Transformation Between These Pathologies | Edocrine Pathology 25: 422-426, 2014 |
7 | Sato K, Shimizu H, Inoue T, Fujimura M, Matsumoto Y, Kondo R, Endo H, Sonoda Y, Tominaga T | Angiographic circulation time and cerebral blood flow during balloon test occlusion of the internal carotid artery | J Cereb Blood Flow Metab 34:(1): 136-143, 2014 |
8 | Ogawa Y, Fujimura M, Tominaga T | Moyamoya syndrome associated with basal meningioma successfully treated by the modified transsphenoidal approach: case report | J Neurol Surg Rep 75(1):e77-80, 2014 |
9 | Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, Tominaga T | Minocycline Prevents Focal Neurologic Deterioration Due to Cerebral Hyperperfusion After Extracranial-Intracranial Bypass for Moyamoya Disease | Neurosurgery 74(2): 163-170, 2014 |
10 | Ogawa Y, Nakata Y, Tominaga T | Post-purchase reassessment and improvement of neuroendoscope holder: importance of physician-manufacturer communication | Technol Health Care 22(2): 397-401, 2014 |
11 | Kawaguchi T, Ogawa Y, Tominaga T | Diagnostic Pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging | BMC ResNotes 20(7): 555, 2014 |
12 | Kawaguchi T, Ogawa Y, Watanabe M, Tominaga T | Craniophyaryngiomas presenting with nonobstructive hydrocephalus; underlying influence of subarachnoidal hemorrhage: Two case reports | J Neurol Surg A Cent Eur Neurosurg, in press |
13 | Ogawa Y, Nakagawa A, Washio A, Arafune T, Tominaga T | Tissue dissection before direct manipulation the pathology with pulsed laser-induced liquid jet system in skull base surgery | J Neurol Surg B Skull Base S2(75): S118, 2014 |
14 | Omodaka S, Endo H, Doi H, Shimizu H, Fujimura M, Aizawa N, Nakazawa T, Tominaga T. | Usefulness of Laser Speckle Flowgraphy for the Assessment of Ocular Blood Flow in Extracranial-Intracranial Bypass. | J Stroke Cerebrovasc Dis 23(10): 445-448, 2014 |
15 | Kondo R, Matsumoto Y, Endo H, Miyachi S, Ezura M, Sakai N | Endovascular Embolization of Cerebral Arteriovenous Malformations: Results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. | Neurol Med Chir (Tokyo) 54(1): 54-62, 2014 |
16 | Shimizu H, Tominaga T, Ogawa A, Kayama T, Mizoi K, Sato K, Terayama Y, Ogasawara K, Mori E, Tohoku Acute Stroke Progressin Stroke Study Group | Cilostazol for the Prevention of Acute Progressing Stroke: A Multicenter, Randomized Controlloed Trial | Journal of Stroke and Cerebrovascular Diseases 22(4): 449-456, 2013 |
17 | Ogawa Y, Watanabe M, Tominaga T | Rathke’s cleft cysts with significant squamous metaplasia- high risk of postoperative deterioration and close origins to craniopharyngioma | Acta Neurochirurgica 155(6): 1069-1057, 2013 |
18 | Ogawa Y, Nakagawa A, Washio T, Arafune T, Tominaga T | Tissue dissection before direct manipulation to the pathology with pulsed laser-induced liquid jet system in skull base surgery - preservation of fine vessels and maintained optic nerve function | Acuta Neurochirurgica 155(10): 1879-1886, 2013 |
19 | Inoue T, Takada S, Shimizu H, Niizuma K, Fujimura M, Sato K, Endo H, Tominaga T | Signal Changes on T2*-Weighted Magnetic Resonance Imaging from the Acute to Chronic Phases in Patients with Subarachnoid Hemorrhage | Cerebrovascular Diseases 36: 421-429, 2013 |
20 | Sugiyama S, Niizuma K, Nakayama T, Shimizu H, Endo H, Inoue T, Fujimura M, Ohta M, Takahashi A, Tominaga T | Relative residence time prolongation in intracranial aneurysms: A possible association with atherosclerosis | Neurosurgery 73(5): 767-776, 2013 |
21 | Ogawa Y, Tominaga T | Thyroid-stimulation hormone-secreting pituitary adenoma presented with recurrent hyperthyroidism in post-treated Graves’ disease: a cace report | J Med Case Rep 7(1), 27, 2013 |
22 | Shimoda Y, Ogawa Y, Watanabe M, Tominaga T | Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistorchemically negative pituitary adenoma - possible involvement in tumor aggressiveness. | Endocr Res 38(4): 242-250, 2013 |
23 | Kawaguchi T, Ogawa Y, Ito K, Watanabe M, Tominaga T | Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman - latent risk of undefined ovarian hyperstimulation: a case report | BMC Res Notes 6:560, 2013 |
24 | Ogawa Y, Tominaga T | Successful treatment of suprasellar tumors associated with poor brain blood perfusion by severe intracranial arterial stenosis: two case reports. | BMC Res Notes 6: 499, 2013 |
25 | Kanoke A, Ogawa Y, Watanabe M, Kumabe T, Tominaga T | Autoimmune hypophysitis presenting with intracranial multi-organ involvement: three case reports and review of the literature. | BMC Res Notes 6: 560, 2013 |
26 | Endo H, Matsumoto Y, Kondo R, Sato K, Fujimura M, Inoue T, Shimizu H, Takahashi A, Tominaga T | Medullary infarction as apoor prognostic factor after internal coil trapping of a ruptured vertebral artery dissection | J Neurosurg 118 (1): 131-139, 2013 |
著者 | 題名 | 論文 | |
1 | Itabashi R, Yazawa Y, Kawata K, Shigehatake Y, Yang S, Otomo K, Furui E. | Paradoxical Brain Emboli Related to Heparin-Induced Thrombocytopenia after Catheter Ablation. | J Stroke Cerebrovasc Dis 2015 Epub ahead of print |
2 | Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Homma K, Matsuki T, Kinoshita N, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI Study Investigators. | Blood glucose levels during the initial 72 h and 3-month functional outcomes in acute intracerebral hemorrhage: the SAMURAI-ICH study. | J Neurol Sci 2015 Epub ahead of print |
3 | Sakamoto Y, Koga M, Todo K, Okuda S, Okada Y, Kimura K, Shiokawa Y, Kamiyama K, Furui E, Hasegawa Y, Kario K, Okata T, Kobayashi J, Tanaka E, Yamagami H, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI study investigators. | Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study. | J Hypertens 33:1069-73, 2015 |
4 | Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Mochizuki H, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Kario K, Sato S, Koga M; SAMURAI Study Investigators. | Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF Study. | Int J Stroke 2015 Epub ahead of print |
5 | Miyagi T, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Minematsu K, Toyoda K. | Reduced estimated glomerular filtration rate affects outcomes 3 months after intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. | J Stroke Cerebrovasc Dis 24: 176-82, 2015 |
6 | Koga M, Arihiro S, Hasegawa Y, Shiokawa Y, Okada Y, Kimura K, Furui E, Nakagawara J, Yamagami H, Kario K, Okuda S, Tokunaga K, Takizawa H, Takasugi J, Sato S, Nagatsuka K, Minematsu K, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. | Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study. | J Stroke Cerebrovasc Dis 23: 2780-7, 2014 |
7 | Itabashi R, Furui E, Sato S, Yazawa Y, Kawata K, Mori E. | Incidence of cardioembolic stroke including paradoxical brain embolism in patients with acute ischemic stroke before and after the Great East Japan Earthquake. | Cerebrovasc Dis. 37:431-7, 2014 |
8 | Tanaka E, Koga M, Kobayashi J, Kario K, Kamiyama K, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Todo K, Kimura K, Okada Y, Okata T, Arihiro S, Sato S, Yamagami H, Nagatsuka K, Minematsu K, Toyoda K. | Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-intracerebral hemorrhage study. | Stroke 45:2275-9, 2014 |
9 | Kobayashi J, Koga M, Tanaka E, Okada Y, Kimura K, Yamagami H, Okuda S, Hasegawa Y, Shiokawa Y, Furui E, Nakagawara J, Kario K, Okata T, Arihiro S, Sato S, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI Study Investigators. | Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. | Stroke 45:868-70, 2014 |
10 | Itabashi R, Mori E, Furui E, Sato S, Yazawa Y, Kawata K, Fujiwara S. | A dilated surface appearance on basiparallel anatomic scanning-magnetic resonance imaging is a useful tool for the diagnosis of spontaneous vertebral artery dissection in lateral medullary infarction. | J Stroke Cerebrovasc Dis 23:805-10, 2014 |
11 | Sakamoto Y, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Arihiro S, Sato S, Kobayashi J, Tanaka E, Nagatsuka K, Minematsu K, Toyoda K; SAMURAI Study Investigators. | Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. | Stroke 44:1846-51, 2013 |
12 | Aoki J, Kimura K, Koga M, Kario K, Nakagawara J, Furui E, Shiokawa Y, Hasegawa Y, Okuda S, Yamagami H, Okada Y, Shibazaki K, Sakamoto Y, Toyoda K. | NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry. | J Neurol Sci 327:6-11, 2013 |
13 | Endo K, Kario K, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Namekawa M, Miyagi T, Osaki M, Minematsu K, Toyoda K. | Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. | Stroke 44:816-8, 2013 |
14 | Kondo R, Matsumoto Y, Furui E, Itabashi R, Sato S, Yazawa Y, Shimizu H, Fujiwara S, Takahashi A, Tominaga T. | Effect of cilostazol in the treatment of acute ischemic stroke in the lenticulostriate artery territory. | Eur Neurol 69:122-8, 2013 |
15 | Miyagi T, Koga M, Shiokawa Y, Nakagawara J, Hasegawa Y, Furui E, Kimura K, Kario K, Okuda S, Yamagami H, Okada Y, Nezu T, Maeda K, Endo K, Minematsu K, Toyoda K. | Intravenous alteplase at 0.6 mg/kg for acute stroke patients with basilar artery occlusion: the stroke acute management with urgent risk factor assessment and improvement (SAMURAI) Recombinant tissue plasminogen activator registry. | J Stroke Cerebrovasc Dis 22:1098-106,2013 |
以下の臨床研究につきましては「人を対象とする生命科学・医学系研究に関する倫理指針」に基づき、研究対象者等への説明と同意を得ずに研究を実施しております。研究対象となる試料・情報の研究への利用又は他の医療機関等への提供について拒否される方は、該当する研究の「問い合わせ先」「担当者」「研究責任者」へご連絡下さい。
医薬品・医療機器は、販売後に安全性と有効性に関する製造販売後調査を実施して、国へ調査結果を報告することが企業の義務として法令で定められております。法令では、製造販売後調査の重要性から、実施に当たり患者さんの同意を必要としていないため、多くの調査が患者さんの同意を得ずに実施されております。しかし、中には調査結果を国へ報告することに併せて、学会や論文などで広く公表することを目的とするものがあります。企業が調査結果を学会や論文などで公表する場合も、患者さん個人を特定する情報が公開されることはありません。もし、調査対象となる試料・情報の研究への利用又は他の医療機関等への提供について拒否される方は、該当する調査の「問い合わせ先」「担当者」「実施責任者」へご連絡下さい。
実施科 実施責任者 |
治験等審査委員会 承認日 |
課題名 |
予定 実施期間 |
---|---|---|---|
血管内脳神経外科 部長 松本康史 |
2020年5月27日 | FREDシステム一般使用成績調査 |
契約締結日~ 2025年3月14日 |
一般財団法人広南会広南病院の研究活動上の不正行為の告発窓口並びに公的研究費の不正使用に係る通報窓口及び不正な取引に関与した業者に対する処分方針について
告発・通報される方は以下の事項をご確認の上、ご連絡ください。
公的研究費の不正使用に加担又は協力したと認められた取引業者に対しては、一定期間の取引停止、業者名の公表、損害賠償請求等の措置を行います。